ONCOLife Issues
Featured Articles
Trending Articles
AI Predicts Who Benefits from Chemotherapy in Breast Cancer Using Routine Pathology Slides
Clinical Trials | 30 March 2026
FDA Approves Agilent’s PD-L1 Test to Guide KEYTRUDA Use in Esophageal and GEJ Carcinoma
FDA & EMA | 28 March 2026
Light-Activated Copper Nanoparticles Trigger Cuproptosis in Drug-Resistant Cancer Cells
ONCOLife | 27 March 2026
New Protein Modification Linked to IDH-Mutant Cancers Opens Therapeutic Possibilities
ONCOLife | 26 March 2026
BioNTech Showcases Promising Bispecific and ADC Data in Lung Cancer at ELCC 2026
ONCOLife | 25 March 2026
Sunvozertinib Outperforms Chemo in First-Line EGFR Exon 20 Insertion NSC Lung Cancer
ONCOLife | 22 March 2026
Magnetic Nanoparticle-Guided Hyperthermia Opens a New Path for Advanced Solid Tumors
ONCOLife | 23 March 2026
TG Therapeutics Secures $500M to Advance BRIUMVI in Relapsing Multiple Sclerosis
Biotech | 20 March 2026
Targeted Bladder Cancer Therapy Erda-iDRS Achieves 89% Response Rate and PDC
ONCOLife | 15 March 2026
Atirmociclib Reduces Progression Risk by 40% in CDK4/6 Metastatic Breast Cancer
ONCOLife | 17 March 2026
TALAPRO-3 Trial Supports Early Use of Talazoparib in HRR+ mCS Prostate Cancer
ONCOLife | 20 March 2026
FDA Approves Nivolumab-AVD as First Immunotherapy Combination for Hodgkin Lymphoma
FDA & EMA | 20 March 2026
Romiplostim Prevents Chemotherapy Side Effects and Preserves Treatment Intensity
ONCOLife
14 March 2026
PSMA PET/CT May Transform Prostate Cancer Diagnosis and Reduce Biopsies by 50%
ONCOLife
13 March 2026
Breast Cancer Patients Choosing Alternative Medicine Face Four Times Higher Mortality
ONCOLife
9 March 2026
Designing Digital Healthcare Systems for the Future of Patient-Centered Care
Digital Health
4 March 2026
Amivantamab Plus Chemotherapy Shows Promising Responses in Colorectal Cancer
Clinical Trials
11 January 2026
Novartis Expands US Radioligand Manufacturing With $23 Billion Investment in Florida
Pharma
9 January 2026
Rewiring RNA: Antisense RNA Therapy Exposes a New Weakness in Pancreatic Cancer
ONCOLife
8 January 2026
TRBC2-Specific ADC Shows Robust Efficacy in T-Cell Lymphomas and Leukemias
Clinical Trials
24 December 2025
FDA Approves First Subcutaneous Amivantamab Plus Lazertinib for EGFR+ Lung Cancer
FDA & EMA
18 December 2025
Platinum-Free PADCEV Plus Pembrolizumab Improves Survival in MI Bladder Cancer
Clinical Trials
18 December 2025
Artificial Intelligence Detects Pancreatic Cancer More Accurately Than Radiologists
AI
12 December 2025
FDA Approves T-DXd Plus Pertuzumab as a First-Line Standard in HER2+ Breast Cancer
FDA & EMA
16 December 2025